Drug shortage
Imatinib Mesylate Tablet · Sun Pharmaceutical Industries Limited
FDA drug shortage · To Be Discontinued · updated Dec 5, 2024
Key facts
| Generic name | Imatinib Mesylate Tablet |
|---|---|
| Proprietary name | Imatinib Mesylate |
| Company | Sun Pharmaceutical Industries Limited |
| Presentation | Imatinib Mesylate, Tablet, 100 mg (NDC 68001-490-05) |
| Dosage form | Tablet |
| Strength | 100 mg |
| Status | To Be Discontinued |
| Therapeutic category | Hematology |
| Package NDCs | 68001-490-05 |
| First posted | Dec 5, 2024 |
| Last updated | Dec 5, 2024 |
| Discontinued | Dec 5, 2024 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: